Literature DB >> 7539274

Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase.

R L Warner1, R Paine, P J Christensen, M A Marletta, M K Richards, S E Wilcoxen, P A Ward.   

Abstract

Products of inducible nitric oxide synthase (iNOS) are known to be involved in lung injury following intrapulmonary deposition of immunoglobulin G immune complexes (IgG-ICx). In the current studies rat alveolar macrophages stimulated in vitro with murine interferon gamma (IFN-gamma), tumor necrosis factor alpha, interleukin 1 alpha, (IL-1 alpha), lipopolysaccharide (LPS), or IgG-ICx immunostained for iNOS and produced nitrite/nitrate- (NO2-/NO3-) in a dose- and time-dependent manner requiring availability of L-arginine. Under the same conditions, IL-4 and IL-10 reduced NO2-/NO3- generation. Type II alveolar epithelial cells, which were obtained from normal rat lungs and stimulated in vitro with IgG-ICx, LPS, or IFN-gamma, also immunostained for iNOS and generated NO2-/NO3-. Special techniques of bronchoalveolar lavage (BAL) were used to retrieve alveolar macrophages and type II alveolar epithelial cells. Under these conditions, intrapulmonary deposition of LPS yielded BAL fluids containing increased amounts of NO2-/NO3- and macrophages that spontaneously released NO2-/NO3- and stained for iNOS. After intrapulmonary deposition of IgG both macrophages as well as type II cells (retrieved by BAL) spontaneously produced NO2-/NO3- and both cell types immunostained for iNOS (approximately 20% of all type II cells and 35% of all alveolar macrophages). Using dual fluorescence staining for cell identification, frozen sections of lung tissue after IgG immune complex deposition revealed iNOS in both alveolar macrophages and type II cells. Finally, in the immune complex model of alveolitis, the appearance of iNOS in macrophages as well as macrophage production in vitro of NO2-/NO3- was dependent on the in vivo availability of tumor necrosis factor alpha, IL-1, and IFN-gamma. These studies suggest a dual cell source for nitric oxide in inflamed lungs and the requirements for iNOS of several cytokines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539274     DOI: 10.1165/ajrcmb.12.6.7539274

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  20 in total

1.  Synergistic enhancement of chemokine generation and lung injury by C5a or the membrane attack complex of complement.

Authors:  B J Czermak; A B Lentsch; N M Bless; H Schmal; H P Friedl; P A Ward
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

2.  Phosphodiesterase 2A is a major negative regulator of iNOS expression in lipopolysaccharide-treated mouse alveolar macrophages.

Authors:  Otgonchimeg Rentsendorj; Franco R D'Alessio; David B Pearse
Journal:  J Leukoc Biol       Date:  2014-07-25       Impact factor: 4.962

3.  Rous-Whipple Award Lecture. Role of complement in lung inflammatory injury.

Authors:  P A Ward
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

4.  Nitric oxide production by rat bronchoalveolar macrophages or polymorphonuclear leukocytes following intratracheal instillation of lipopolysaccharide or silica.

Authors:  L J Huffman; D J Prugh; L Millecchia; K C Schuller; S Cantrell; D W Porter
Journal:  J Biosci       Date:  2003-02       Impact factor: 1.826

5.  Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen.

Authors:  M Kolpen; T Bjarnsholt; C Moser; C R Hansen; L F Rickelt; M Kühl; C Hempel; T Pressler; N Høiby; P Ø Jensen
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

6.  Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells.

Authors:  Roberto Loi; Travis Beckett; Kaarin K Goncz; Benjamin T Suratt; Daniel J Weiss
Journal:  Am J Respir Crit Care Med       Date:  2005-09-22       Impact factor: 21.405

7.  Streptococcal cysteine protease augments lung injury induced by products of group A streptococci.

Authors:  T P Shanley; D Schrier; V Kapur; M Kehoe; J M Musser; P A Ward
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

8.  Preservation of complement-induced lung injury in mice with deficiency of NADPH oxidase.

Authors:  H Kubo; D Morgenstern; W M Quinian; P A Ward; M C Dinauer; C M Doerschuk
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

9.  In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13.

Authors:  A B Lentsch; T P Shanley; V Sarma; P A Ward
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

10.  Abrogation of anti-inflammatory transcription factor LKLF in neutrophil-dominated airways.

Authors:  Milene T Saavedra; Abby D Patterson; James West; Scott H Randell; David W Riches; Ken C Malcolm; Carlyne D Cool; Jerry A Nick; Charles A Dinarello
Journal:  Am J Respir Cell Mol Biol       Date:  2008-01-24       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.